THE earliest recognition of leukaemia as a distinct disease entity can be dated with some accuracy to three independent reports of cases, each published in 1845, by (Craigie, Bennett and Virchow. The view that the leukaemias are neoplastic diseases apparently was first proposed by Babes in 1902 and it is of interest that even as late as 1938 Forkner, in his scholarly monograph " Leukemia and Allied Disorders ", listed three major possibilities regarding the nature of leukaemia-infection, regulator disorder or neoplasm-none of which was overwhelmingly supported by the experimental or clinical evidence then available.
The view held by most workers today is that the leukaemias are neoplastic diseases. The general clinical features of the leukaemias progressive, ultimately fatal, diseases involving the accumulation of abnormal numbers of primitive white cells, often in abnormal locations fit the pattern of other forms of cancer. Despite the fact that none of the various forms of leukaemia in animals is a particularly accurate model of the human diseases, work on the nature of leukaemia in animals, particularly mice, has obviously had an overwhelming impact on modern views on the human diseases.
Many lines of evidence suggest that leukaemia in animals is a neoplastic disease. Agents such as irradiation and methylcholanthrene, which are able to induce carcinomata in various tissues in animals, are also leukaemogenic. Possibly the most convincing experiments proving the neoplastic nature of murine leukaemia were the demonstrations by Furth and Kahn (1937) that leukaemia could be transplanted to mice by the injection of a single leukaemic cell, and also the subsequent work of others showing that the cells of transplanted leukaemias are derived from the progressive proliferation of the original transplanted cells.
The clonal nature of an abnormal population is highly suggestive, if not conclusive, evidence for a neoplastic process. Karyotypic studies on mouse leukaemias have shown the clonal nature of some leukaemic populations and parallel studies on certain acute leukaemias in humans where the cells possessed karyotypic markers have suggested also that leukaemic populations can be clonal in nature (Sandberg et al., 1964; Jensen, 1967) . Recent work on patients with chronic granulocytic leukaemia who are heterozygous for the G-6-PD locus has also suggested that the leukaemic population can be clonal (Fialkow, Gartler and Yoshida, 1967) . However, no information yet exists on the nature of chronic lymphoid leukaemic populations.
Attachment of the label " cancer " to a disease process is of course merely to beg the question " What is cancer? " The word appears deceptively simple until one attempts a precise definition which is sufficiently broad to cover all forms of cancer. A useful definition is still that given by Furth (1959) : "Neoplasia is a 1 In 1965 a semi-solid agar culture system was developed which supports the clonal proliferation of mouse granulocytic and monocytic-inacrophage cells (Bradley and Metcalf, 1966; Ichikawa, Pluznik and Sachs, 1966) . The technique was subsequently modified by Pike and Robinson (1970) (Metcalf, Bradley and Robinson, 1967; Cline, Warner and Metcalf, 1972) in a manner which reproduces events occurring in vivo during granulopoiesis and monocyte formation.
It is important to emphasize that this is a primary culture system which always uses marrow, spleen or blood cells taken directly from the animal or patient and answers questions relating to the cultured cells as they existed in the body. It is not concerned with the long-term growth characteristics of these cells on continued cultivation in vitro. (Worton, McCulloch and Till, 1969; Haskill, McNeill and Moore, 1970; Metcalf, and Moore, 1971 (Moore, Williams and Metcalf, 1972) . In fact, most colonies initially contain granulocytic populations, some members of which then switch to the alternative monocyte-macrophage pathway as colony growth proceeds (Metcalf et al., 1967; Metcalf, 1971) . The agar culture studies have clearly shown that monocytes and macrophages are closely related to granulocytes and have a common precursor cell the in vitro CFC. This provides the explanation for the observation in humans and animals that monocytic populatioins are commonly abnormal in myeloid leukaemia, often to the degree of causing the leukaemia to be classified as myelomonocytic. In fact, analysis of a myelomonocytic leukaemia in mice demonstratedl that both the granulocytic and monocytic populations share(d a common leukaemic progenitor cell (colony-forming cell) and were members of the same neoplastic clone (Warner, Moore and Metcalf, 1969; Metcalf, Moore and Warner, 1969) . Similar studies have been made on a myeloid leukaemia in mice (Ichikawa, 1969 (Ichikawa, , 1970 in which it was demonstrated that undifferentiated leukaemic cells could be induced in agar culture to generate clones of mature granulocytes and macrophages.
The various myeloid, myelomonocytic and monocytic leukaemias are probably best regarded as a continuous spectrum in which one cell population or the other is involved in the leukaemic process to a greater or lesser degree.
There is a characteristic heterogeneity in the size of granulocytic and macrophage colonies developing in agar cultures of bone marrow cells which appears to be based on a decreasing capacity for proliferation of the progressively more mature progeny of the progenitor cells. Thus small colonies seem to be generated by the progeny of cells forming large colonies whereas clusters are generated by the progeny of cells forming small colonies. Analysis of the size and frequency pattern of colonies and clusters appears to be a useful method for characterizing the pattern of differentiation existing in the population at the time of sampling (Metcalf and Stevens, 1972) and is a technique which has obvious applications in determining the exact location of a block in cellular proliferation in many human diseases, e.g. aplastic anaemia, agranulocytosis, drug-induced neutropenia, etc.
Colony formation in vitro by marrow cells is dependent entirely on the presence in the culture medium of a specific glycoprotein, colony stimulating factor (CSF), which has a concentration-dependent effect on the number and growth rate of colonies developing in the culture (Metcalf, 1970) . Agar cultures of mouse bone marrow cells can be used as a highly sensitive bioassay system for both mouse and human CSF and will detect concentrations of less than 100 pg/ml . CSF is a neuraminic acid-containing glycoprotein, and is detectable in all normal human sera and urines (Chan, Metcalf and Stanley, 1971; Stanley et al., 1972) . In human urine, CSF has a molecular weight of 45,000 but the CSFs extractable from many tissues, although having simi-lar biological activity, vary considerably in size and charge (Sheridan and Stanley, 1971; Austin, McCulloch and Till, 1971; Bradley, Stanley and Sumner, 1971; Sheridan and Metcalf, 1972) .
Studies of CSF levels in mice and humans during fluctuations in the level of granulopoiesis or monocyte formation, together with observations on the in vivo effects of injected preparations of CSF, suggest that CSF is a humoral regulator of granulopoiesis and monocyte formation (Bradley et al., 1969; Metcalf and Stanley, 1971; Metcalf and Moore, 1971; Morley et al., 1971) .
Lipoproteins are demonstrable in normal human and mouse serum and are termed " CSF inhibitors " because they exert a species-specific blocking action in vitro on CSF although the inhibitors do not appear to be cytotoxic for colonyforming cells Chan, 1971) . The exact role played by CSF inhibitors in the intact animal remains to be clarified but they are tentatively regarded as modulating the stimulating effects of CSF on granulopoiesis and monocyte formation.
The curious situation has been documented that a common progenitor cell (the in vitro CFC) generates both granulocytic and macrophage progeny and that proliferation in both of the alternate cellular pathways is regulated by a single regulator-CSF . This requires the existence of an accessory mechanism for determining the relative proportions of cells entering one or other pathway. In part this seems to be determined by the concentration of CSF, with low CSF concentrations favouring entry into the monocyte-macrophage pathway, and vice versa. However, a more important accessory mechanism appears to involve the CSF inhibitors. In the presence of these inhibitors, colony differentiation switches prematurely to the monocyte-macrophage pathway and preincubation of in vitro CFCs with inhibitors has a similar end result when these cells are subsequently cultured in an inhibitorfree system (Chan, 1971) . Observations on mice with high and low serum inhibitor levels suggest that this mechanism may also operate in vivo.
The agar culture system therefore allows two types of studies in humans (a) an assessment of the number and proliferative status of granulocytic and monocytic progenitor cells and their progeny in any tissue, and (b) the assay of two regulators of their proliferation and differentiation CSF and CSF inhibitors.
It is important to emphasize that there are probably other regulatory mechanisms controlling these cell populations which have not yet been identified. One known gap in technology is the inability to quantitate haemopoietic stem cells in the agar culture system and also the inability to obtain colony-forming cell progeny from these cells under controlled conditions. It is not possible therefore to assess in humans the behaviour of the haemopoietic stem cells and a consequence of this will be discussed later in relation to patients with acute myeloid leukaemia. It is possible that more recent culture systems may support the production of in vitro CFCs by stem cells (Dicke, Platenburg and Van Bekkum, 1971; McCulloch and Till, 1971; Sumner et al., 1972; Testa and Lajtha, 1972 ) but this has not been documented using a purified starting population of stem cells. Most circumstantial evidence from observations in vivo suggests that the generation of progenitor cells from stem cells requires a cell-contact, inductive, interaction between stem cells and tissue microenvironmental cells (Metcalf and Moore, 1971) . Culture systems capable of permitting this sophisticated type of cell-cell interaction are not yet available.
The heterogeneity of tissue CSFs has raised many problems concerning their interrelationships and significance. In this context, certain evidence suggests that the CSF produced locally in the marrow may be a major factor determining the level of granulopoiesis and monocyte formation (Chan and Metcalf, 1972, 1973; .
Observations in grey collie dogs with cyclic neutropenia suggest that CSF levels fluctuate periodically in an out-of-phase relationship with neutrophil levels (Dale et al., 1971) and it has been suggested that polymorphs and/or monocytes and macrophages may operate feedback systems controlling CSF production (Paran et al., 1968; Robinson and Pike, 1970; Moore, Williams and Metcalf, 1973) . This may regulate basal production of CSF but observations on humans and animals with infections Kirchmyer, 1968, 1968a; Metcalf and Wahren, 1968) or mice following the injection of bacterial antigens (Metcalf, 1971a; Shadduck et at., 1972) suggest that the entry of microbial products into the body is the primary factor determining major fluctuations in CSF production.
Culture of blood or marrow cells from patients with leukaemia Human cells, like cells from all other species except the mouse, exhibit some colony formation in the absence of added CSF. This is due to the presence of CSFproducing cells in these suspensions Greenberg et al., 1971; Moore et al., 1973a) . The most obvious abnormality is the greatly increased incidence of colony-forming cells in the marrow and particularly the blood, where levels may be up to 50,000-fold above normal (Paran et al., 1970; Moore et al., 1973a) . Indeed, it is usual to find a higher frequency of colony-forming cells per 105 nucleated cells in the blood than in the marrow. Karyotypic studies of the dividing cells in such colonies have demonstrated the Ph+ chromosomal abnormality in colony cells although Ph-cells have been described in colonies grown from some CML patients (Chervenick et al., 1971; . The colony-forming cells in these patients have been shown to differ significantly from normal cells (a) in possessing longer cell cycle times or being more often in a Go (non-cycling) state and (b) in having a significantly lighter buoyant density as assessed by centrifugation in bovine serum albumin (Moore et al., 1972a (Moore et al., , 1973a .
In remission, patients with CML exhibit normal numbers of colony-forming cells and these cells have a normal cell cycle status and near-normal buoyant density. Persistence of Ph+ colonies has been reported in cultures from some patients in remission.
Although agar-proliferating cells from untreated patients with acute myeloid leukaemia (AML) exhibit similar abnormalities of cell cycle status and buoyant density to those described above for CML colony-forming cells, they can readily be distinguished from CML cells by their quite different proliferative behaviour in agar (Iscove et al., 1971; Greenberg et al., 1971 ; Brown and Carbone, 1971; Moore et al., 1972a Moore et al., , 1973a (Harris and Freireich, 1970; Greenberg et al., 1971 ) and suich cells have a normal cell cycle status and buoyant density (Moore et al., ] 973a). The colonies generated are of normal size and contain cells which differentiate normally and exhibit a normal karyotypic pattern.
Some untreated AML patients, variously classified as subacute ML, do possess colony-forming cells in the blood and marrow but these cells have the above cell cycle and density abnormalities. The colonies generated may exhibit karyotypic abnormalities if such abnormalities are present in the leukaemic population in vivo (Duttera et al., 1972; .
The growth pattern of cells from patients with acute myelomonocytic leukaemia is similar to that of cells from patients with AML. When CML patients enter blast crisis, the leukaemic cells behave in essentially the same manner as cells from patients with AML, either being unable to proliferate in agar or capable only of forming small clusters (Paran et al., 1970; Moore et al., 1973a) .
These data from the behaviour in cultutre of AML and CML cells are a little puzzling in that they suggest that the leukaemic process affects a more ancestral granulocytic cell in CML (the colonyforming cell) than in AML (the clusterforming cell). It may be, however, that the clusters appearing in cultures of AML cells are not generated by cells at an equivalent level of maturation to those generating clusters in normal marrow populations. Clusters in cultures of AML cells are generated by myeloblasts (Moore et al., 1973a) Levels of CSF and CSF inhibitors have been studied extensively in patients with AML and in less detail in CML patients . All patients so far studied with AML exhibited elevated serum or urine CSF levels at some stage in their disease, with levels sometimes rising fifty-fold above normal. Such rises were sometimes associated with the development of infections but patients in relapse rather characteristically tended to be unable to exhibit the normal response of elevated seruin and urine CSF levels during such episodes of infections. More than half of the sera tested from AML patients were found to have subnormal or undetectable CSF-inhibitor levels (Chan and Metcalf, 1970; Metcalf et al., 197 1) . Occasional sera with subnormal inhibitor levels have been observed in other types of leukaemia and other diseases, but the frequency of such sera is low and inhibitors are rarely completely undetectable. The only other situation in which inhibitor levels have been found to be uniformly low is in CML patients who are in terminal blast crisis . Most sera from uncomplicated CML patients have high CSF levels but normal inhibitor levels.
Preleukaemic changes
The agar culture system is a(dmnirably suited for studies of the nature of granulopoietic cell populations and regulator levels in patients before overt leukaemia develops. Are there antecedent abnormalities or does leukaemia develop against a background of normal haemopoietic function?
As leukaemia is relatively uncommon, it is not practicable to screen populations at random in an attempt to detect cellular or regulator abnormalities in the preleukaemic period. However, some information has been gathered on cellular and humoral abnormalities in various haematological diseases carrying a higher than normal risk of subsequient leuikaemia development, e.g. polycythaemia vera, aplastic anaemia, refractory sideroblastic anaemia, paroxysmal noctuirnal haemoglobinuria, agnogenic myeloid metaplasia. Many specimens of serum and urine from these patients exhibited elevated CSF levels . Again, some of these could be discounted on the grounds that the patient had a concurrent infection but on many occasions there was no clinical evidence of an infection. Less frequently, abnormally low serum CSF inhibitor levels were observed.
The status of the colony-forming cells in the marrow of these patients is of coInsiderable interest. Kurnick, Robinson and Dickey (19] 71) and Greenberg et al. (19.71) have reported a subnormal incidence of in vitro (1FCs in the marrow of patients with granulocytopenia and aplastic anaemia. Intriguing informationi is emerging from a sequential stucdy which has so far analysed 45 potentially preleukaemic patients, two ofwhom have since developed leuLkaemia (Moore and W; 11illiams, unpublished data (Metcalf, unpublished data) but further work is required on this question. An alternative possibility is that the AML or preleukaemic cells may activate a specific feedback system shutting down granulopoiesis because sensor systems monitoring total body granulocytes are activated both by leukaemic and normal cells, but normal cells are more susceptible to feedback inhibition. This latter alternative may be more likely in CML where the progeny of the leukaemic population do exhibit relatively good differentiation.
Leaving aside the reasons why leukaemic or preleukaemic cells have a competitive advantage over normal cells, the commonly observed combination of high CSF levels and low inhibitor levels in preleukaemic and leukaemic patients, together with the observation that leukaemic cells are responsive to stimulation by CSF, raises the possibility that development and progression of myeloid leukaemia may be significantly influenced by this regulator imbalance. Of possible additional relevance is the observation that high concentrations of CSF tend to cause the progeny of colony-forming cells to remain undifferentiated and capable of further divisions .
Evidence from the analysis of myeloid leukaemia development in mice is of particular interest in this context. In certain mouse strains, e.g. the Rf, irradiation can induce myeloid leukaemia development and some evidence suggests that disease development is initiated by the activation of a latent C-type leukaemia virus. In distinction from the results following irradiation of conventional Rf mice, irradiation of germfree Rf mice does not cause myeloid leukaemia development although such mice can develop myeloid leukaemia if subsequently conventionalized (Upton et al., 1966) . The possible involvement of CSF in this process is indicated by observations on CSF levels in germ-free mice. Germ-free mice have abnormally low serum CSF levels (Metcalf, Foster and Pollard, 1967a) , emphasizing the role of bacterial products in provoking CSF production by the tissues. Furthermore, serum CSF levels in germ-free mice are not elevated by whole-body irradiation, as occurs following irradiation of conventional mice (Morley et al., 1971 . It seems possible therefore that the capacity of C-type viruses to induce myeloid leukaemia development may be dependent on a sufficient proliferative pressure being applied by CSF on the virus-altered granulopoietic cells to force the emergence of an abnormal (leukaemic) subpopulation.
The stepwise emergence of progressively more abnormal granulopoietic populations in potentially preleukaemic patients seems to be occurring often in the presence of elevated serum CSF levels and low inhibitor levels and it is possible that a similar situation may exist to that in the 
